Target Product Profile (TPP) for Chagas Disease Point-of-Care Diagnosis and Assessment of Response to Treatment

Affiliations

• ¹ Pan American Health Organization, Regional Office of the World Health Organization, Washington, D.C., United States of America.
• ² Servicio de Parasitología y Chagas, Hospital de Niños Ricardo Gutiérrez, Ciudad de Buenos Aires, Argentina.
• ³ Laboratório de Biologia Molecular e Doenças Endêmicas, Oswaldo Cruz Institute, Laboratory of Molecular Biology and Endemic Diseases, FIOCRUZ, Rio de Janeiro, Brazil.
• ⁴ Sergio Arouca National School of Public Health, FIOCRUZ, Rio de Janeiro, Brazil.
• ⁵ Médecins Sans Frontières-Médecins Sans Frontières Operational Center Barcelona-Athens (OCBA), Barcelona, Spain.
• ⁶ René Rachou Research Center, Laboratory of Biomarkers of Diagnostic and Monitoring, Oswaldo Cruz Institute, Minas Gerais, Brazil.
• ⁷ Latin America Regional Office, Drugs for Neglected Diseases initiative, Rio de Janeiro, Brazil.
• ⁸ Laboratorio de Biología Molecular de la Enfermedad de Chagas, Instituto de Investigaciones en Ingeniería Genética y Biología Molecular "Dr Hector Torres" (INGEBI-CONICET), Buenos Aires, Argentina.
• ⁹ Department of Infectious and Parasitic Diseases, Faculdade de Medicina, University of São Paulo, Sao Paulo, Brazil.
• ¹⁰ Instituto Nacional de Parasitología, Dr. Mario Fatala Chaben ANLIS, Ministerio de Salud, Buenos Aires, Argentina.
• ¹¹ Center for Technological Development in Health, Oswaldo Cruz Foundation, (FIOCRUZ), Rio de Janeiro, Brazil.